Asia Pacific Breast Imaging market is anticipated to grow at 9.86% CAGR from 2018 to 2023 and it is estimated that the Asia Pacific market was valued at USD 0.52 billion in 2018 and is expected to reach USD 0.83 billion by 2023.
In medicine, breast imaging is the representation or reproduction of a breast's form. There are various methods of breast imaging. Scintimammography is a type of breast imaging test that involves detection of cancer cells in the breasts of some women who have had abnormal mammograms, or for those who have dense breast tissue, post-operative scar tissue or breast implants, but is not used for screening or in place of a mammogram.
The increasing incidences of breast cancer, the increasing awareness about the early diagnosis of breast cancer, and the growing number of investments to introduce technology upgrades in the present imaging systems are the preliminary factors that are anticipated to drive the market growth over the forecast period. Technological improvements in the breast imaging devices have led to the emergence of countries in the Asia-Pacific region, which are expected to generate high growth opportunities for the existent market players. Be that as it may, regulatory approval procedures, high system installation costs, health risks due to radiation exposure from the mammography machines, and an unfavorable reimbursement scenario in the developing countries are key factors hindering the market growth.
The Asia Pacific Breast Imaging market is segmented on the basis of Type. On the basis of Type, it is segmented into Pellets, Bales, and Cubes. On the basis of Application, it is segmented into Ionizing Technologies and Non-ionizing Technologies. The ionizing segment is further segmented into Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, and PEM. The Non-ionizing segment is further sub-segmented into Breast Ultrasound, AWBU, Breast Thermography, Breast MRI, and Optical Imaging. The mammography segment accounted for the major share of the market due to the technological advancements in the mammography instruments, for instance, the introduction of the portable and digital mammography instruments are expected to further aid the market growth. The digital mammography equipment provides advantages such as reduced examination times and space requirement for data storage consequently leading the tomography segment to witness lucrative growth as compared to other imaging systems.
Based on geography, the market is segmented into India, China, Japan, Australia and South Korea. Asia Pacific is expected to register the highest CAGR in the coming years. Acquisitions and new product development endeavors in the growing economies of India and China are expected to further boost the growth of the breast imaging market over the forecast period. Moreover, factors such as improvements in the healthcare infrastructure, the rising investment, and the multi-national industrial growth within this region along with the increase in the number of government initiatives to raise awareness are driving the market growth in this region.
Some of the key players dominating the market are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Ionizing Technologies
5.1.2.1 Mammography
5.1.2.2 Digital Mammography
5.1.2.3 3D Mammography
5.1.2.4 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
5.1.2.5 Positron Emission Tomography and Computed Tomography (PET-CT)
5.1.2.6 Cone-Beam Computed Tomography (CBCT)
5.1.2.7 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
5.1.3.1 Breast MRI
5.1.3.2 Breast Ultrasound
5.1.3.3 Automated Whole-Breast Ultrasound (AWBU)
5.1.3.4 Breast Thermography
5.1.3.5 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
